⌘K

Login Start Free

Home/Filings/4/0001562180-23-007594

4//SEC Filing

Shah Pritesh 4

Accession 0001562180-23-007594

CIK 0001645113other

View on SEC.gov Company Profile

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 4:22 PM ET

Size

4.9 KB

Accession

0001562180-23-007594

Insider Transaction Report

Form 4

Period: 2023-11-07

NovoCure LtdNVCR

Chief Commercial Officer

Transactions

Sale
Ordinary Shares
2023-11-07$12.65/sh−382$4,832→ 124,511 total

Footnotes (1)

[F1]Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1

filerCIK 0001744884

Filing Metadata

Form type: 4
Filed: Nov 7, 7:00 PM ET
Accepted: Nov 8, 4:22 PM ET
Size: 4.9 KB

View on SEC.gov